OpenExamsFREE PRACTICE — ANY EXAM

Maine Pharmacist — Requirements & Free Practice

US-ME · License preparation

449 free questions · Answer explanations · No signup required

Choose what to practice

Start with an exam below. Your examination requirements depend on your application pathway. View licensing requirements

Combined practice

Loading selected examination banks…

Licenses, application pathways and examination requirements

Each license and applicant pathway has its own requirements and exemptions. Choosing practice questions does not determine your eligibility.

Pharmacist

License to engage in the practice of pharmacy in Maine, issued by the Maine Board of Pharmacy.

Licensing authority: Maine Board of Pharmacy · Application information

Licensure by reciprocity/endorsement
Fee
Pay the license fee (10 M.R.S. §8003-H(3)); the Board page lists a $75.00 reciprocity/endorsement fee and a $21.00 criminal background check fee.
Good Standing
Good standing in all jurisdictions in which the applicant holds or has held a license: no pending complaint, allegation or investigation, no suspended or restricted license, never surrendered or had a license revoked (10 M.R.S. §8003-H(1)).
Jurisprudence Examination
10 M.R.S. §8003-H permits the Board to require a jurisprudence examination; the Board page for reciprocity/endorsement states 'Complete and pass the MPJE via NABP.'
Licensure Elsewhere
Proof of licensure by another jurisdiction of the United States that maintains substantially equivalent license requirements for pharmacists (32 M.R.S. §13733-A; 10 M.R.S. §8003-H).
Nabp Licensure Transfer
Submit the NABP Preliminary Application for Transfer of Pharmaceutic Licensure with the Maine application, the $96.00 fee payable to Maine State Treasurer, proof of age, official transcripts, license verification(s), good moral character form, proof of internship if applicable, and criminal conviction and disciplinary documentation if applicable (Board licensing page).
Naplex Passed For Original Licensure
The NAPLEX passing score is the one the applicant earned for licensure elsewhere; 02-392 C.M.R. ch. 4 §1(3) requires every applicant to demonstrate NAPLEX and MPJE passing scores and also accepts predecessors of either examination or a Board-recognized successor.
No Cause For Denial
No cause for denial under 10 M.R.S. §8003(5-A)(A) or any other law (10 M.R.S. §8003-H(2)).
Prior Discipline Or Conviction
The Board may refuse licensure for prior disciplinary action or a conviction involving controlled substances, subject to waiver (02-392 C.M.R. ch. 4 §1(7)).
Licensure by examination (graduate of an accredited pharmacy degree program)
Age
Have attained the age of 21 years (32 M.R.S. §13732(1)(B)).
Application And Fee
Written application in the form prescribed by the Board with the required examination and license fee (32 M.R.S. §13732(1)(A)); the Board page lists a $75.00 license fee and a $21.00 criminal background check fee.
Education
First professional degree from a pharmacy degree program accredited by the American Council on Pharmaceutical Education (32 M.R.S. §13732(1)(D)); 02-392 C.M.R. ch. 4 §1(4)(A) requires an official transcript from an ACPE- or CCAPP-accredited school, accreditation including pre-candidate and candidate status.
Filing Timing
The Board asks applicants not to file the Maine application until the required NABP examinations have been passed; NABP confirms eligibility to test for Maine.
Internship
Completed an internship or other Board-approved program, or demonstrated to the Board's satisfaction pharmacy practice experience meeting or exceeding the minimum internship requirement (32 M.R.S. §13732(1)(E)); written verification that the internship meets 02-392 C.M.R. ch. 6-A (ch. 4 §1(4)(B)).
Predecessor Or Successor Examinations
02-392 C.M.R. ch. 4 §1(3) also accepts passing scores on predecessors of the NAPLEX or MPJE, or on any successor to either of them recognized by the Board.
Prior Discipline Or Conviction
Verification of licensure in every jurisdiction where the applicant has been licensed or registered; the Board may refuse licensure for prior disciplinary action or a conviction involving controlled substances, subject to waiver (02-392 C.M.R. ch. 4 §1(7)).
Licensure by examination (foreign pharmacy graduate with FPGEC Certificate)
Age
Have attained the age of 21 years (32 M.R.S. §13732(1)(B)).
Application And Fee
Written application in the form prescribed by the Board with the required examination and license fee (32 M.R.S. §13732(1)(A)); the Board page lists a $75.00 license fee and a $21.00 criminal background check fee.
Education
First pharmacy degree earned outside the United States from a college not subject to AACP or CCAPP accreditation (02-392 C.M.R. ch. 4 §1(6)); 32 M.R.S. §13732(1)(D) accepts a degree from an equivalent Board-approved program from a school outside the United States.
Filing Timing
The Board asks applicants not to file the Maine application until the required NABP examinations have been passed; NABP confirms eligibility to test for Maine.
Fpgec Certificate
Present a Foreign Pharmacy Graduate Examination Committee (FPGEC) Certificate issued by NABP and meet all other requirements of law and rule (02-392 C.M.R. ch. 4 §1(6)). The Maine sources name the certificate, not an examination.
Internship
Completed an internship or other Board-approved program, or demonstrated to the Board's satisfaction pharmacy practice experience meeting or exceeding the minimum internship requirement (32 M.R.S. §13732(1)(E)); written verification that the internship meets 02-392 C.M.R. ch. 6-A (ch. 4 §1(4)(B)).
Predecessor Or Successor Examinations
02-392 C.M.R. ch. 4 §1(3) also accepts passing scores on predecessors of the NAPLEX or MPJE, or on any successor to either of them recognized by the Board.
Prior Discipline Or Conviction
Verification of licensure in every jurisdiction where the applicant has been licensed or registered; the Board may refuse licensure for prior disciplinary action or a conviction involving controlled substances, subject to waiver (02-392 C.M.R. ch. 4 §1(7)).
Reactivation of an inactive renewal license to active practice
No examination is required for this applicant pathway.
Continuing Education
Proof satisfactory to the Board of at least 15 hours of approved continuing professional pharmaceutical education during the calendar year preceding the application for active licensure; the Board may make exceptions in emergency or hardship cases (32 M.R.S. §13734(2)).
Inactive License
Holds a Maine inactive renewal license (Inactive Pharmacist or Inactive Senior Pharmacist).
Written Request
Submit a written request to the Board (Board licensing page).

Official no-examination sources

Effective from 2025-10-20.

Annual renewal of an active pharmacist license
No examination is required for this applicant pathway.
Continuing Education
Certify at least 15 hours of Board-approved continuing professional pharmaceutical education in the preceding calendar year, including at least 2 hours on drug administration for pharmacists authorized to administer drugs and immunizations and 5 hours in the agreement's practice areas for pharmacists in a collaborative practice agreement (32 M.R.S. §13735); the Board may make exceptions in emergency or hardship cases.
Late Renewal
Renewal is possible up to 90 days after expiration with a $50 late fee; later applications fall under the renewal-after-90-days route (32 M.R.S. §13734(1)).
Renewal Request
Written or online renewal request with the renewal fee ($75.00 annually; licenses expire December 31) (32 M.R.S. §13734(1); Board licensing page).

Official no-examination sources

Effective from 2025-10-20.

Renewal application more than 90 days after expiration
Examination Waiver
The Board may, giving due consideration to the protection of the public, waive examination if the renewal application is made within 2 years from the date of expiration (32 M.R.S. §13734(1)).
Late Application
A renewal application submitted more than 90 days after the license expiration date is subject to all requirements governing new applicants, including a late fee, renewal fee and additional late fee (32 M.R.S. §13734(1)); the Board page requires reapplication with the original license application, documentation and fees.
New Applicant Requirements
The applicant otherwise meets the requirements of the route under which a new applicant in the same position would apply (licensure by examination, score transfer or endorsement).
Licensure by examination with NAPLEX score transfer
Age
Have attained the age of 21 years (32 M.R.S. §13732(1)(B)).
Application And Fee
Written application in the form prescribed by the Board with the required examination and license fee (32 M.R.S. §13732(1)(A)); the Board page lists a $75.00 license fee and a $21.00 criminal background check fee.
Education
First professional degree from an accredited pharmacy degree program (32 M.R.S. §13732(1)(D); 02-392 C.M.R. ch. 4 §1(4)(A)).
Filing Timing
The Board asks applicants not to file the Maine application until the required NABP examinations have been passed; NABP confirms eligibility to test for Maine.
Internship
Completed an internship or other Board-approved program, or demonstrated to the Board's satisfaction pharmacy practice experience meeting or exceeding the minimum internship requirement (32 M.R.S. §13732(1)(E)); written verification that the internship meets 02-392 C.M.R. ch. 6-A (ch. 4 §1(4)(B)).
Naplex Score Transfer
NAPLEX taken for another jurisdiction and its score transferred to Maine through NABP's Score Transfer Program (02-392 C.M.R. ch. 4 §1(5)); a NAPLEX score transfer supporting licensure by examination is valid only for one year from the date the passing score was achieved (ch. 4 §1(4)).
Predecessor Or Successor Examinations
02-392 C.M.R. ch. 4 §1(3) also accepts passing scores on predecessors of the NAPLEX or MPJE, or on any successor to either of them recognized by the Board.
Prior Discipline Or Conviction
Verification of licensure in every jurisdiction where the applicant has been licensed or registered; the Board may refuse licensure for prior disciplinary action or a conviction involving controlled substances, subject to waiver (02-392 C.M.R. ch. 4 §1(7)).

Collaborative Drug Therapy Management

License authorizing a Maine-licensed pharmacist to practice collaborative drug therapy management pursuant to a collaborative practice agreement.

Licensing authority: Maine Board of Pharmacy · Application information

Issuance to a Maine licensed pharmacist or with a Maine pharmacist license application
No examination is required for this applicant pathway.
Collaborative Practice Agreement
Practice under a collaborative practice agreement submitted to the Board (32 M.R.S. §13843; 02-392 C.M.R. ch. 39 and 39-A).
Fee
No license fee (Board licensing page).
License
Hold a valid unrestricted Maine pharmacist license (32 M.R.S. §13842(1)); a person without a Maine pharmacist license may apply for both at the same time (Board licensing page).
Training
Certification from the Board of Pharmacy Specialties or successor organization, or an accredited residency program (with a 15-hour continuing education certificate program in each clinical area covered by the agreement if the residency is in another area); or a Doctor of Pharmacy degree from an ACPE-accredited college, 2 years of professional experience and a 15-hour continuing education certificate program in each clinical area; or a Bachelor of Science in Pharmacy degree from an ACPE-accredited college, 3 years of professional experience and a 15-hour continuing education certificate program in each clinical area (32 M.R.S. §13842(2)).

Official no-examination sources

Effective from 2025-10-20.

Annual renewal with the pharmacist license
No examination is required for this applicant pathway.
Continuing Education
5 of the 15 required continuing education hours in the areas of practice covered by the collaborative practice agreement (32 M.R.S. §13735).
Renewal
Renews annually on December 31 with the pharmacist license; no fee (Board licensing page).

Official no-examination sources

Effective from 2025-10-20.

Certificate of Administration

Board-issued certificate authorizing a Maine-licensed pharmacist to administer drugs and immunizations.

Licensing authority: Maine Board of Pharmacy · Application information

Issuance to a Maine licensed pharmacist or with a Maine pharmacist license application
No examination is required for this applicant pathway.
Application And Fee
Application in the form prescribed by the Board with the certificate fee (32 M.R.S. §13832(1)); the Board page lists $20.00.
Didactic And Practical Course
Satisfactorily complete a Board-approved didactic and practical course covering the subjects listed in 32 M.R.S. §13832(4).
License
Hold a valid unrestricted Maine pharmacist license (32 M.R.S. §13832(2)); an applicant for a Maine pharmacist license may request the authorization on the license application (Board licensing page).
Life Support Training
Evidence of cardiovascular life support training accepted by the American Heart Association, the American Red Cross or a similar organization (32 M.R.S. §13832(5)).
Training
Evidence of a 20-hour course of study in drug administration within the 3 preceding years, or a Doctor of Pharmacy degree from an ACPE-accredited college within the 3 preceding years including the required training, or a valid certificate of administration from another U.S. jurisdiction within the 3 preceding years with continuous administration practice (32 M.R.S. §13832(3)).

Official no-examination sources

Effective from 2025-10-20.

Annual renewal with the pharmacist license
No examination is required for this applicant pathway.
Continuing Education
At least 2 of the 15 required continuing education hours in Board-approved courses on drug administration (32 M.R.S. §13735).
Renewal
The certificate of administration expires and is subject to the conditions in the same manner as the pharmacist license under 32 M.R.S. §13734 (32 M.R.S. §13832(1)); annual renewal fee $20.00 (Board licensing page).

Official no-examination sources

Effective from 2025-10-20.

Contraceptive Authorization

Board-issued certificate of authorization required for a pharmacist to prescribe, dispense and administer self-administered or injectable hormonal contraceptives.

Licensing authority: Maine Board of Pharmacy · Application information

Issuance to a Maine licensed pharmacist
No examination is required for this applicant pathway.
Application And Fee
Board application with the fee set by OPOR rule Chapter 10; incomplete applications are voided after 60 days (02-392 C.M.R. ch. 44 §2).
License
Active Maine pharmacy license (02-392 C.M.R. ch. 44 §2).
Training
Within the 3 preceding years, completion of an ACPE-approved training program for hormonal contraceptives, or receipt of a Doctor of Pharmacy degree from an ACPE-accredited college that included training in contraception; attested on the application (02-392 C.M.R. ch. 44 §3; 32 M.R.S. §13826(3)(A)).

Official no-examination sources

Effective from 2025-10-20.

Annual renewal with the pharmacist license
No examination is required for this applicant pathway.
Current Practice
Attest at annual license renewal to remaining current with best practices for prescribing, dispensing and administering hormonal contraceptives (02-392 C.M.R. ch. 44 §3).
Renewal
The authorization expires annually at the same time as the pharmacist license and is renewed in the same manner (02-392 C.M.R. ch. 44).

Official no-examination sources

Effective from 2025-10-20.

Inactive Pharmacist

Inactive renewal license for a Maine-licensed pharmacist under the age of 65 who is not currently practicing pharmacy in Maine.

Licensing authority: Maine Board of Pharmacy · Application information

Change of an active Maine pharmacist license to inactive status
No examination is required for this applicant pathway.
Eligibility
Maine-licensed pharmacist under the age of 65 who is not currently practicing pharmacy in Maine (Board licensing page).
Fee
Inactive renewal fee as set under 32 M.R.S. §13724; the Board page lists $10.00 annually.
Written Request
Written request to the Board to change the license to inactive status (Board licensing page).

Official no-examination sources

Effective from 2025-10-20.

Annual renewal of the inactive license
No examination is required for this applicant pathway.
Continuing Education
No continuing education is required for renewal while on inactive status (Board licensing page).
Fee
Pay the annual inactive renewal fee on or before the expiration date ($10.00; expires December 31) (32 M.R.S. §13734(2); Board licensing page).
Lapse
If the inactive renewal is not procured within 30 days, the original license expires; regaining licensure requires one renewal fee plus all fees in arrears (32 M.R.S. §13734(2)).

Official no-examination sources

Effective from 2025-10-20.

Inactive Senior Pharmacist

Inactive renewal license for a Maine-licensed pharmacist age 65 or over who is not currently practicing pharmacy in Maine.

Licensing authority: Maine Board of Pharmacy · Application information

Change of an active Maine pharmacist license to inactive status
No examination is required for this applicant pathway.
Eligibility
Maine-licensed pharmacist age 65 or over who is not currently practicing pharmacy in Maine (Board licensing page).
Fee
Inactive renewal fee as set under 32 M.R.S. §13724; the Board page lists $10.00 annually.
Written Request
Written request to the Board to change the license to inactive status (Board licensing page).

Official no-examination sources

Effective from 2025-10-20.

Annual renewal of the inactive license
No examination is required for this applicant pathway.
Continuing Education
No continuing education is required for renewal while on inactive status (Board licensing page).
Fee
Pay the annual inactive renewal fee on or before the expiration date ($10.00; expires December 31) (32 M.R.S. §13734(2); Board licensing page).
Lapse
If the inactive renewal is not procured within 30 days, the original license expires; regaining licensure requires one renewal fee plus all fees in arrears (32 M.R.S. §13734(2)).

Official no-examination sources

Effective from 2025-10-20.

multistate pharmacy jurisprudence examination

Provider
National Association of Boards of Pharmacy (NABP); appointments scheduled with Pearson
Format
Computer-based adaptive exam with selected-response questions
Exam questions
120
Time limit
2.5 hours
Passing score
Results reported as pass or fail; 5 attempts per jurisdiction
Examination outline
  • Maine Pharmacy Act (32 M.R.S. ch. 117)
  • Board of Pharmacy Rules ch. 1: Definitions
  • Board of Pharmacy Rules ch. 3: Applicability of Rules to Unregistered Facilities
  • Board of Pharmacy Rules ch. 4: Licensure of Pharmacists
  • Board of Pharmacy Rules ch. 4-A: Administration of Drugs and Vaccines and Operation of a Drug or Vaccine Administration Clinic
  • Board of Pharmacy Rules ch. 5: Continuing Pharmacy Education
  • Board of Pharmacy Rules ch. 6-A: Pharmacy Student Internship Programs
  • Board of Pharmacy Rules ch. 7: Licensure and Employment of Pharmacy Technicians
  • Board of Pharmacy Rules ch. 8: Licensure of Retail Pharmacies
  • Board of Pharmacy Rules ch. 9: Registration of Rural Health Centers
  • Board of Pharmacy Rules ch. 10: Registration of Free Clinics
  • Board of Pharmacy Rules ch. 11: Registration of Mail Order Prescription Pharmacies and Licensure of Mail Order Contact Lens Suppliers
  • Board of Pharmacy Rules ch. 12: Licensure of Manufacturers and Wholesalers
  • Board of Pharmacy Rules ch. 13: Operation of Retail Pharmacies
  • Board of Pharmacy Rules ch. 14: Pharmacy Services at Rural Health Centers
  • Board of Pharmacy Rules ch. 15: Operation of Free Clinics
  • Board of Pharmacy Rules ch. 16: Operation of Wholesalers and Manufacturers
  • Board of Pharmacy Rules ch. 17: Operation of Nuclear Drug Outlets
  • Board of Pharmacy Rules ch. 19: Receipt and Handling of Prescription Drug Orders
  • Board of Pharmacy Rules ch. 20: Automated Pharmacy Systems
  • Board of Pharmacy Rules ch. 20-A: Self-Service Customer Kiosks
  • Board of Pharmacy Rules ch. 21: Central Prescription Processing
  • Board of Pharmacy Rules ch. 22: Sale of Schedule V Controlled Substances
  • Board of Pharmacy Rules ch. 23: Accounting for Prescription Drugs
  • Board of Pharmacy Rules ch. 24: Retention of Records by Pharmacies
  • Board of Pharmacy Rules ch. 25: Patient Counseling
  • Board of Pharmacy Rules ch. 26: Generic Substitution
  • Board of Pharmacy Rules ch. 28: Enforcement and Disciplinary Procedures
  • Board of Pharmacy Rules ch. 29: Violations of State or Federal Law or Rule; Other Standards
  • Board of Pharmacy Rules ch. 30: Unprofessional Conduct
  • Board of Pharmacy Rules ch. 31: Practice of Fraud or Deceit
  • Board of Pharmacy Rules ch. 32: Issuance of Citations
  • Board of Pharmacy Rules ch. 33: Access to Certain Medications by Certified Midwives
  • Board of Pharmacy Rules ch. 34: Licensure of Retail Suppliers of Medical Oxygen
  • Board of Pharmacy Rules ch. 35: Licensure of Extended Hospital Pharmacies
  • Board of Pharmacy Rules ch. 37: Licensure of Sterile Compounding Pharmacies
  • Board of Pharmacy Rules ch. 38: Licensure of Closed-Shop Pharmacies
  • Board of Pharmacy Rules ch. 39: Collaborative Drug Therapy Management (joint rule with Board of Licensure in Medicine ch. 5)
  • Board of Pharmacy Rules ch. 39-A: Collaborative Drug Therapy Management (joint rule with State Board of Nursing ch. 1)
  • Board of Pharmacy Rules ch. 40: Authorization, Training and Procedures for Prescribing and Dispensing Naloxone Hydrochloride
  • Board of Pharmacy Rules ch. 41: Sales of Nonprescription Drugs through Vending Machine Outlets
  • Board of Pharmacy Rules ch. 42: Compounding Drugs for Veterinarian Office Use
  • Board of Pharmacy Rules ch. 43: Prescribing, Dispensing and Administering HIV Prevention Drugs
  • Board of Pharmacy Rules ch. 44: Pharmacist Authorization to Make Certain Contraception Accessible
  • 21 CFR Part 1300: Definitions
  • 21 CFR Part 1301: Registration of Manufacturers, Distributors, and Dispensers of Controlled Substances
  • 21 CFR Part 1302: Labeling and Packaging Requirements for Controlled Substances
  • 21 CFR Part 1304: Records and Reports of Registrants
  • 21 CFR Part 1305: Orders for Schedule I and II Controlled Substances
  • 21 CFR Part 1306: Prescriptions
  • 21 CFR Part 1307: Miscellaneous
  • 21 CFR Part 1308: Schedules of Controlled Substances
  • 21 CFR Part 1309: Registration of Manufacturers, Distributors, Importers and Exporters of List I Chemicals
  • 21 CFR Part 1310: Records and Reports of Listed Chemicals and Certain Machines; Importation and Exportation of Certain Machines
  • 21 CFR Part 1311: Requirements for Electronic Orders and Prescriptions
  • 21 CFR Part 1312: Importation and Exportation of Controlled Substances
  • 21 CFR Part 1313: Importation and Exportation of List I and List II Chemicals
  • 21 CFR Part 1314: Retail Sale of Scheduled Listed Chemical Products
  • 21 CFR Part 1316: Administrative Functions, Practices, and Procedures
  • 21 CFR Part 1317: Disposal
  • 21 CFR Part 1321: DEA Mailing Addresses
Examination sources

North American Pharmacist Licensure Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
225 questions
Time limit
6 hours
Passing score
Pass or Fail
Examination outline
  • Foundational Knowledge for Pharmacy Practice (25%)
    • Pharmaceutical science principles and concepts
    • Pharmaceutical science principles and concepts: Pharmacology
    • Pharmaceutical science principles and concepts: Pharmacokinetics, pharmacodynamics, or pharmacogenomics
    • Pharmaceutical science principles and concepts: Pharmaceutics
    • Pharmaceutical compounding
    • Pharmaceutical compounding: Nonsterile preparations
    • Pharmaceutical compounding: Sterile preparations
    • Pharmaceutical calculations
    • Pharmaceutical calculations: Patient parameters or laboratory measures
    • Pharmaceutical calculations: Quantities of drugs to be dispensed or administered
    • Pharmaceutical calculations: Rates of administration
    • Pharmaceutical calculations: Dose conversions
    • Pharmaceutical calculations: Drug concentrations, ratio strengths, osmolarity, or osmolality
    • Pharmaceutical calculations: Quantities of drugs or ingredients to be compounded
    • Pharmaceutical calculations: Nutritional needs and the content of nutrient sources
    • Pharmaceutical calculations: Biostatistical, epidemiological, or pharmacoeconomic measures
    • Pharmaceutical calculations: Pharmacokinetic parameters
    • Drug development processes (eg, clinical trial phases, emergency use authorizations)
    • Research design principles and biostatistics (eg, blinding, randomization, biases, statistical tests and outcomes, ethics)
    • Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (25%)
    • Prescriptions and medication order interpretation
    • Prescriptions and medication order interpretation: Drug names and therapeutic classes
    • Prescriptions and medication order interpretation: Indications, usage, and dosing regimens
    • Prescriptions and medication order interpretation: Available dosage forms
    • Prescriptions and medication order interpretation: Prescription regulations (eg, boxed warnings, risk evaluation and mitigation strategies)
    • Prescriptions and medication order interpretation: Safety and effectiveness (eg, laboratory parameters, vital signs)
    • Therapeutic substitutions (eg, formulary restrictions, therapeutic alternatives, shortages, biosimilars)
    • Immunization services and documentation
    • Immunization services and documentation: Indications and scheduling
    • Immunization services and documentation: Contraindications and precautions
    • Immunization services and documentation: Storage and handling
    • Immunization services and documentation: Administration (eg, techniques, preparation, routes)
    • Immunization services and documentation: Adverse reactions
    • Medication handling, storage, stability, and disposal (eg, hazardous and nonhazardous drugs, controlled substances, parenteral medications, sharps handling, temperature control)
  • Person-Centered Assessment and Treatment Planning (40%)
    • Medication history, allergy history, and reconciliation
    • Health histories, screenings, and assessments
    • Patient health conditions, including special populations and medication-related factors
    • Patient health conditions, including special populations and medication-related factors: Signs, symptoms, and findings of medical conditions, etiology of diseases, or pathophysiology
    • Patient health conditions, including special populations and medication-related factors: Appropriateness of therapy (eg, medications, immunizations, non-drug therapy, dosing, contraindications, warnings, evidence-based decision making)
    • Patient health conditions, including special populations and medication-related factors: Interactions (eg, drug-drug, drug-condition, drug-food, drug-allergy, drug-laboratory)
    • Patient health conditions, including special populations and medication-related factors: Errors and omissions (eg, dosing, duplication, additional therapy needed, unnecessary therapy)
    • Patient health conditions, including special populations and medication-related factors: Adverse drug reactions
    • Patient health conditions, including special populations and medication-related factors: Toxicologic exposures and overdoses
    • Patient health conditions, including special populations and medication-related factors: Adherence
    • Therapeutic monitoring, plan development, evaluation, and modifications
    • Therapeutic monitoring, plan development, evaluation, and modifications: Therapeutic goals, clinical endpoints, and follow-up
    • Therapeutic monitoring, plan development, evaluation, and modifications: Safety
    • Therapeutic monitoring, plan development, evaluation, and modifications: Effectiveness
    • Patient education
    • Patient education: Lifestyle modifications and health maintenance
    • Patient education: Medication use, storage, and disposal
    • Patient education: Disease state management
    • Over-the-counter medications and dietary supplements
    • Devices to administer medications and self-monitoring tests
  • Professional Practice (5%)
    • Adverse drug event reporting and medication error reporting (eg, MedWatch, VAERS)
    • Public health initiatives and risk-prevention programs (eg, tobacco and nicotine cessation, antimicrobial stewardship, health screenings, opioid stewardship)
    • Social determinants and drivers of health
    • Ethical considerations (eg, informed consent, ethical principles, professional conduct and responsibility, patient confidentiality)
  • Pharmacy Management and Leadership (5%)
    • Pharmacy operations (eg, operational planning, risk management, regulations and regulatory bodies, technology applications and informatics, error-prevention strategies, medication safety)
    • Inventory and supply management (eg, drug recalls, drug shortages)
    • Quality improvement activities (eg, medication use evaluation, root-cause analysis, continuous quality improvement)
    • Mentorship and preceptorship (eg, providing and receiving feedback, delegation of work activities, preceptor roles)
Examination sources